Editorial
COPD: A preventable epidemic?
EPOC: ¿una epidemia prevenible?
a Servicio de Medicina Interna, Hospital Universitario Virgen del Rocío, Sevilla, Spain
b Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain
c Instituto de Biomedicina de Sevilla, Sevilla, Spain
d Grupo de Trabajo de EPOC de la Sociedad Española de Medicina Interna, Spain
e Departamento de Medicina, Universidad de Sevilla, Sevilla, Spain
Read
10
Timeswas read the article
4
Total PDF
6
Total HTML
Share statistics
array:24 [ "pii" => "S2254887422000297" "issn" => "22548874" "doi" => "10.1016/j.rceng.2022.02.001" "estado" => "S300" "fechaPublicacion" => "2022-04-01" "aid" => "2017" "copyright" => "Sociedad Española de Medicina Interna (SEMI)" "copyrightAnyo" => "2022" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Rev Clin Esp. 2022;222:233-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0014256522000194" "issn" => "00142565" "doi" => "10.1016/j.rce.2022.02.002" "estado" => "S300" "fechaPublicacion" => "2022-04-01" "aid" => "2017" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Rev Clin Esp. 2022;222:233-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "EPOC: ¿una epidemia prevenible?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "233" "paginaFinal" => "234" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "COPD: A preventable epidemic?" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "José Manuel Varela-Aguilar, Francisco Javier Medrano-Ortega" "autores" => array:2 [ 0 => array:2 [ "nombre" => "José Manuel" "apellidos" => "Varela-Aguilar" ] 1 => array:2 [ "nombre" => "Francisco Javier" "apellidos" => "Medrano-Ortega" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2254887422000297" "doi" => "10.1016/j.rceng.2022.02.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887422000297?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256522000194?idApp=WRCEE" "url" => "/00142565/0000022200000004/v1_202204130553/S0014256522000194/v1_202204130553/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S2254887421001223" "issn" => "22548874" "doi" => "10.1016/j.rceng.2020.11.012" "estado" => "S300" "fechaPublicacion" => "2022-04-01" "aid" => "1940" "copyright" => "The Author(s)" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Rev Clin Esp. 2022;222:235-40" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Special article</span>" "titulo" => "Consensus on the management of hyperkalemia in patients with heart failure: Recommendations from the SEC-SEMI" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "235" "paginaFinal" => "240" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Consenso sobre el manejo de la hiperpotasemia en pacientes con insuficiencia cardíaca: recomendaciones de la SEC-SEMI" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1862 "Ancho" => 2675 "Tamanyo" => 227788 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Algorithm for management according to potassium levels.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "L. Almenar Bonet, Á. González-Franco" "autores" => array:3 [ 0 => array:2 [ "nombre" => "L." "apellidos" => "Almenar Bonet" ] 1 => array:2 [ "nombre" => "Á." "apellidos" => "González-Franco" ] 2 => array:1 [ "colaborador" => "Working Group for the Study of Hyperkalemia" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0014256521000175" "doi" => "10.1016/j.rce.2020.11.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256521000175?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887421001223?idApp=WRCEE" "url" => "/22548874/0000022200000004/v1_202204130611/S2254887421001223/v1_202204130611/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2254887421001016" "issn" => "22548874" "doi" => "10.1016/j.rceng.2021.04.002" "estado" => "S300" "fechaPublicacion" => "2022-04-01" "aid" => "1962" "copyright" => "Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI)" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "Rev Clin Esp. 2022;222:229-32" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Brief original</span>" "titulo" => "Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "229" "paginaFinal" => "232" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Metaanálisis para evaluar el riesgo de infecciones respiratorias y síndrome de distrés respiratorio del adulto con los agonistas del receptor del péptido similar al glucagón tipo 1 en los ensayos de seguridad cardiovascular: consecuencias útiles para la pandemia de COVID-19" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 853 "Ancho" => 3174 "Tamanyo" => 299425 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Effect of GLP-1-RA treatment compared to placebo on the risk for lower respiratory tract infection.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "D. Patoulias, A. Boulmpou, K. Imprialos, K. Stavropoulos, C. Papadopoulos, M. Doumas" "autores" => array:6 [ 0 => array:2 [ "nombre" => "D." "apellidos" => "Patoulias" ] 1 => array:2 [ "nombre" => "A." "apellidos" => "Boulmpou" ] 2 => array:2 [ "nombre" => "K." "apellidos" => "Imprialos" ] 3 => array:2 [ "nombre" => "K." "apellidos" => "Stavropoulos" ] 4 => array:2 [ "nombre" => "C." "apellidos" => "Papadopoulos" ] 5 => array:2 [ "nombre" => "M." "apellidos" => "Doumas" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0014256521001028" "doi" => "10.1016/j.rce.2021.04.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0014256521001028?idApp=WRCEE" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887421001016?idApp=WRCEE" "url" => "/22548874/0000022200000004/v1_202204130611/S2254887421001016/v1_202204130611/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "COPD: A preventable epidemic?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "233" "paginaFinal" => "234" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "J.M. Varela-Aguilar, F.J. Medrano-Ortega" "autores" => array:2 [ 0 => array:3 [ "nombre" => "J.M." "apellidos" => "Varela-Aguilar" "referencia" => array:4 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 3 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] 1 => array:4 [ "nombre" => "F.J." "apellidos" => "Medrano-Ortega" "email" => array:1 [ 0 => "medrano@cica.es" ] "referencia" => array:6 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] 3 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] 4 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">e</span>" "identificador" => "aff0025" ] 5 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:5 [ 0 => array:3 [ "entidad" => "Servicio de Medicina Interna, Hospital Universitario Virgen del Rocío, Sevilla, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Instituto de Biomedicina de Sevilla, Sevilla, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Grupo de Trabajo de EPOC de la Sociedad Española de Medicina Interna, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] 4 => array:3 [ "entidad" => "Departamento de Medicina, Universidad de Sevilla, Sevilla, Spain" "etiqueta" => "e" "identificador" => "aff0025" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "EPOC: ¿una epidemia prevenible?" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease characterised by persistent respiratory symptoms and limited airflow due to alveolar and/or airway abnormalities, generally caused by significant exposure to noxious particles and influenced by host factors, including abnormal lung development.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">COPD represents an important public health challenge and is a significant cause of morbidity and mortality and public health care costs. In 2019 it was estimated that 212 million patients were diagnosed with COPD around the world with over 3.2 million deaths each year, representing the third cause of death (6% of deaths) and the sixth in terms of disease burden.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> The projections indicate that the burden of COPD will increase in coming decades due to continuous exposure to the disease’s risk factors and to population ageing.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">COPD is the most prevalent non-communicable respiratory disease and has reached pandemic levels. The data on the real prevalence of COPD varies broadly due to differences in diagnostic and inclusion criteria and significant geographic variability, with a prevalence of diagnosed cases that ranges from 6% in Europe to 1.6% in sub-Saharan Africa.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> A good example of this is the study published by Wang et al. that was conducted in the vast Shanxi province (China), where a prevalence of 6.4% was observed,<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> though the results could be biased as it included an excessively young population (≥20 years).</p><p id="par0020" class="elsevierStylePara elsevierViewall">Fortunately, we currently have data that enables us to estimate the prevalence of COPD more accurately, such as the Burden of Obstructive Lung Diseases (BOLD) program that uses a standardised methodology to evaluate the prevalence and risk factors of COPD in individuals over the age of 40 across the world.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> According to BOLD, the number of real cases of COPD in 2010 was estimated to be 384 million, with a global prevalence of 11.7%.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">In Spain, recent data from the EPISCAN II study show a prevalence of 11.8% in patients over the age of 40, with significant regional differences and a predominance in males (14.6%) over females (9.4%). This latter group is increasingly growing as it progressively adopts smoking habits.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> This prevalence is higher than that of other diseases such as diabetes mellitus and yet, we continue to fail to pay enough attention to our respiratory health.</p><p id="par0030" class="elsevierStylePara elsevierViewall">The two basic pillars in the fight against this epidemic are interventions to prevent risk factors and early diagnosis of the disease. The main risk factors for COPD are smoking, presence of respiratory symptoms (wheezing, asthma and/or chronic bronchitis) and a history of sinusitis or nasal polyps.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">In our setting, prevention should be focused on fighting smoking. According to the European Health Survey, in Spain, 16.4% of females and 23.3% of males smoke on a daily basis.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> The strategy should be focused around preventing starting smoking and helping current smokers to stop smoking. For this reason, the current anti-smoking law from 2010 needs to be revised to help stop tobacco use.</p><p id="par0040" class="elsevierStylePara elsevierViewall">In terms of early diagnosis, the significant underdiagnosis of COPD is a crucial issue, estimated to be around 74.7% in Spain according to the EPISCAN II data.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> This means that up to 70% of COPD patients are diagnosed in advanced stages of the disease when the possibility to improve prognosis is much more limited.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p><p id="par0045" class="elsevierStylePara elsevierViewall">To reduce underdiagnosis, our GesEPOC national guidelines continue to recommend the use of screening questionnaires and spirometry in adults over 35 years, smokers, or ex-smokers with respiratory symptoms.<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> However, it is necessary to evaluate new strategies regarding both the use of simpler screening methods than spirometry and a definition of the target population for screening. For the former, this includes the use of questionnaires, portable spirometers, or peak flow meters as well as more innovative techniques, such as analysing breathing sounds recorded by smartphones, which are already being implemented in initiatives to anticipate diagnosis and treatment of this disease such as the ANTES multi-centre strategy.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> Regarding the latter, advances must be made in the analysis of the cost effectiveness of screening in diseases like ischaemic heart disease, diabetes, or sinusitis, where the prevalence of COPD is very high and screening opportunistic.</p><p id="par0050" class="elsevierStylePara elsevierViewall">In short, if we want to make progress in the fight against COPD, we must strengthen measures to reduce tobacco use and once and for all define strategies that enable hidden cases of the disease to come to the surface.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "⋆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Varela-Aguilar JM, Medrano-Ortega FJ. EPOC: ¿una epidemia prevenible? Rev Clin Esp. 2022;222:233–234.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:11 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "2022 reports. Global strategy for prevention, diagnosis and management of COPD" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Global Initiative for Chronic Obstructive Lung Disease" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Libro" => array:1 [ "fecha" => "2022" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "GBD 2019 Diseases and Injuries Collaborators" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(20)30925-9" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2020" "volumen" => "396" "paginaInicial" => "1204" "paginaFinal" => "1222" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33069326" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "GBD Chronic Respiratory Disease Collaborators" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S2213-2600(20)30105-3" "Revista" => array:6 [ "tituloSerie" => "Lancet Respir Med" "fecha" => "2020" "volumen" => "8" "paginaInicial" => "585" "paginaFinal" => "596" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32526187" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Encuesta poblacional sobre la prevalencia y los factores de riesgo de la enfermedad pulmonar obstructiva crónica en la provincia de Shanxi (China)" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "R. Wang" 1 => "J. Xu" 2 => "R. Wang" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Clin Esp" "fecha" => "2022" "volumen" => "222" "paginaInicial" => "218" "paginaFinal" => "221" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "BOLD. Burden of Obstructive Lung Disease Initiative Webpage, published by Imperial College London. Available from: <a target="_blank" href="http://www.boldstudy.org/">http://www.boldstudy.org/</a>. [Accessed 30 January 2022]." ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Global and regional estimates of COPD prevalence: systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Adeloye" 1 => "S. Chua" 2 => "C. Lee" 3 => "C. Basquill" 4 => "A. Papana" 5 => "E. Theodoratou" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.7189/jogh.05-020415" "Revista" => array:3 [ "tituloSerie" => "J Glob Health" "fecha" => "2015" "volumen" => "5" ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence and determinants of COPD in Spain EPISCAN II" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Soriano" 1 => "I. Alfageme" 2 => "M. Miravitlles" 3 => "P. de Lucas" 4 => "J.J. Soler-Cataluña" 5 => "F. García-Rio" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arbres.2020.07.024" "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2021" "volumen" => "57" "paginaInicial" => "61" "paginaFinal" => "69" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32950310" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Factors associated with low lung function in different age bins in the general population" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "R. Breyer-Kohansal" 1 => "R. Faner" 2 => "M.-K. Breyer" 3 => "A. Ofenheimer" 4 => "A. Schrott" 5 => "M. Studnicka" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.202001-0172LE" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2020" "volumen" => "202" "paginaInicial" => "292" "paginaFinal" => "329" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32255673" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:1 [ "referenciaCompleta" => "Instituto Nacional de Estadística. Encuesta Europea de Salud en España. Available from: <a target="_blank" href="https://www.ine.es/dyngs/INEbase/es/operacion.htm?c=Estadistica_C&cid=1254736176784&menu=resultados&idp=1254735573175">https://www.ine.es/dyngs/INEbase/es/operacion.htm?c=Estadistica_C&cid=1254736176784&menu=resultados&idp=1254735573175</a>. [Accessed 6 February 2022]." ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Guía de Práctica Clínica para el Diagnóstico y Tratamiento de Pacientes con Enfermedad Pulmonar Obstructiva Crónica (EPOC)-Guía Española de la EPOC (GesEPOC) Versión 2017" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "Grupo de Trabajo de GesEPOC" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2017" "volumen" => "53 Supl 1" "paginaInicial" => "1" "paginaFinal" => "64" ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Time for a change: anticipating the diagnosis and treatment of COPD" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A. Agusti" 1 => "B. Alcazar" 2 => "B. Cosio" 3 => "J.M. Echave" 4 => "R. Faner" 5 => "J.L. Izquierdo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1183/13993003.02104-2020" "Revista" => array:3 [ "tituloSerie" => "Eur Respir J" "fecha" => "2020" "volumen" => "56" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/22548874/0000022200000004/v1_202204130611/S2254887422000297/v1_202204130611/en/main.assets" "Apartado" => array:4 [ "identificador" => "75844" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Editorial" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/22548874/0000022200000004/v1_202204130611/S2254887422000297/v1_202204130611/en/main.pdf?idApp=WRCEE&text.app=https://revclinesp.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2254887422000297?idApp=WRCEE" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2023 March | 5 | 4 | 9 |
| 2022 April | 1 | 0 | 1 |
